Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Fluphenazine | |
| Synonyms |
|
|
| Definitions |
A phenothiazine with antipsychotic activity. Fluphenazine exerts its actions by blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia. This prevents the actions of dopamine, thereby reducing the hallucinations and delusions that are associated with schizophrenia. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C47536 |
|
| ALT_DEFINITION |
A drug that is used to treat mental and emotional disorders and is being studied in the treatment of multiple myeloma. Fluphenazine may stop tumor growth by keeping myeloma cells from dividing and causing them to die. It is a type of antipsychotic.
|
|
| CAS_Registry |
69-23-8
|
|
| CHEBI_ID |
CHEBI:5123
|
|
| Chemical_Formula |
C22H26F3N3OS
|
|
| code |
C47536
|
|
| Contributing_Source |
FDA
|
|
| definition |
A phenothiazine with antipsychotic activity. Fluphenazine exerts its actions by blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia. This prevents the actions of dopamine, thereby reducing the hallucinations and delusions that are associated with schizophrenia.
|
|
| FDA_UNII_Code |
S79426A41Z
|
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Fluphenazine
|
|
| Legacy Concept Name |
Fluphenazine
|
|
| NSC Number |
62323
|
|
| Preferred_Name |
Fluphenazine
|
|
| prefixIRI |
NCIT:C47536
|
|
| prefLabel |
Fluphenazine
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C0016368
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping